Possibility of medicinal correction of disorders in metabolic cycle of neurotoxic transmitter glutamate in retina with neurotropic drugs during experimental glaucoma
DOI:
https://doi.org/10.14739/2310-1237.2012.2.16756Keywords:
glaucoma, glutamate, glutamine, glutamine synthetase, glutamate oxidase, glutaminase, memantine, citicolineAbstract
Adult rabbits with experimental glaucoma were used in this study. We studied glutamate and glutamine levels and glutamine synthetase, glutamate oxidase and glutaminase activity in the eye tissue during glaucoma process. Results suggest increase of both glutamate level and glutaminase activity, as well as decrease of both glutamine level and glutamine synthetase and glutamate oxidase activity compared to normal ranges over all period of observation. This influence was significally prevented using neuroprotective drugs.References
Алексеев В.Н. Роль апоптоза и метаболизма мюллеровских клеток при экспериментальной глаукоме / Алексеев В.Н., Мартынова Е.Б., Самусенко И.А. // Клин. Офтальмол. – 2005. – №5. – С. 52–55.
Алябьева Ж.Ю. Сосудистые факторы риска в развитии глаукомы с нормальным давлением / Алябьева Ж.Ю // Клинич. Офтальмол. – 2001. – Т. 2, № 2. – С. 6–8.
Бунин А.Я. Метаболические факторы патогенеза первичной открыто-угольной глаукомы / Бунин А.Я. // Матер. науч.-практич. конференции: «Глаукома: итоги и перспективы на рубеже тысячелетий» – М., 1999. – С. 9–12.
Волков В.В. Трехкомпонентная классификация открыто-угольной глаукомы на основе представлений о ее патогенезе / Волков В.В. // Глаукома. – 2004. – №1. – C. 57–67.
Наследов А. SPSS компьютерный анализ данных в психологии и социальных науках / Наследов А. – СПб.: Питер, 2005. – 416 с.
Agar A. Retinal ganglion cell line apoptosis induced by hydrostatic pressure / Agar A., Li S.// Brain Res. – 2006. – V. 1086. – P. 191–200.
Benozzi J. Effect of hyaluronic acid on intraocular pressure in rats / Benozzi J., Nahum L.P., Campanelli J.L. // Invest. Ophthalmol. Vis. Sci. – 2002. – V. 43. – P. 2196–2200.
Bergmeyer H.U. Methoden der enzymatischen Analyse. / Herausgegeben von H.U. Bergmeyer. – Berlin, 1986. – S. 2254–2265.
Carter-Dawson L. Vitreal glutamate concentration in monkeys with experimental glaucoma / Carter-Dawson L., Crawford M.L., Harwerth R.S. // Investigative Ophthalmology & Visual Science. – 2002. – V. 43, №8. – P. 2633–2637.
Danbolt N.C. Glutamate uptake./ Danbolt N.C. // Prog. Neurobiol. – 2001. – Vol. 65. – P. 101–105.
Dreyer E.B. Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma / Dreyer E.B. Surakowski D., Schumer R. A. // Arch. Ophthalmol. – 1996. – V. 114. – P. 299–305.
Flammer J. Vascular Dysregulation: A principal risk factor for glaucomatous damage? / Flammer J., Haefliger I. //J. Glaucoma. – 1999. – Vol. 8. – P. 212–219.
Gulati V. Monitoring glaucoma in the developing world / Gulati V., Agarwal H., Sihota R. // Asian J. Ophthalmol. – 2002. – Vol. 4, №1. – P. 3–8.
Guo L. Assessment of neuroprotective effects of glutamate modulation on glaucoma related retinal ganglion cell apoptosis in vivo / Guo L., Salt T. E., Maass A. // Invest. Ophthalmol. Vis. Sci. – 2006. – V. 47. – P. 626–633.
Harada T. The potential role of glutamate transporters in the pathogenesis of normal tension glaucoma / Harada T., Harada C., Nakamura K. // J. Clin. Invest. – 2007. – V. 117, №7. – P. 1763–1770.
Heijl A. Reduction of intraocular pressure and glaucoma progression / Heijl A., Leske C. // Arch. Ophthalmol. – 2002. – V. 120. – P. 1268–1279.
Kusari J. Effect of mementhine on neuroretinal function and retinal vascular changes of streptozotocin-induced diabetic rats / Kusari J., Zhou S., Padillo E. // Invest. Ophthalmol. Vis. Sci. – 2007. – Vol. 48. – P. 5152–5159.
Lagreze W.A. Neuroprotection in ischemia of the retina an animal model / Lagreze W. A., Otto T., Feuerstein T. J. // Ophthalmologe. – 1999. – Vol. 96, №6. – P. 370–374.
Moreno M.C. Effect of glaucoma on the retinal glutamate/glutamine cycle activity / Moreno M.C., Sande P., Marcos H. A. // FASEB J. – 2005. – V. 19. – №9. – P. 1161–1162.
Neufeld A. New conceptual approaches for pharmacological neuroprotection in glaucomatous neuronal degeneration / Neufeld A. //J. Glaucoma. – 1998. – Vol. 7, №6. – P. 434–438.
Quigley H.A. The number of people with glaucoma worldwide in 2010 and 2020 / Quigley H.A., Broman A.T. // Br. J. Ophthalmol. – 2006. – Vol. 90. – P. 262–267.
Ritch R. The Glaucomas / Ritch R., Shields M., Krupin T. – St. Luis: CV Mosby, 1996. – 432 p.
Schroder A. Einsatz von memanthine bei glaucoma fere absolutum / Schroder A., Erb C. // Klin. Monatsbl. Augenheilkd. – 2002. – Vol. 219. – P. 533–536.
Yoles E. Elevation of intraocular glutamate levels in rats with partial lesion of the optic nerve / Yoles E., Schwartz M.// Arch. Ophthalmol. – 1998. – V. 116. – P. 906–910.
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (SeeThe Effect of Open Access).
